|
ZNF823 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.909000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.118000E-01 |
| Normal-vs-Stage2 |
5.873800E-01 |
| Normal-vs-Stage3 |
9.054600E-01 |
| Normal-vs-Stage4 |
4.528800E-01 |
| Stage1-vs-Stage2 |
3.815400E-01 |
| Stage1-vs-Stage3 |
6.291200E-01 |
| Stage1-vs-Stage4 |
1.476210E-01 |
| Stage2-vs-Stage3 |
7.648600E-01 |
| Stage2-vs-Stage4 |
8.253000E-01 |
| Stage3-vs-Stage4 |
5.771200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.957800E-01 |
| Normal-vs-AfricanAmerican |
4.861800E-01 |
| Normal-vs-Asian |
1.097840E-01 |
| Caucasian-vs-AfricanAmerican |
3.806800E-01 |
| Caucasian-vs-Asian |
1.628970E-01 |
| AfricanAmerican-vs-Asian |
3.410600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.888200E-01 |
| Normal-vs-Female |
2.677000E-01 |
| Male-vs-Female |
1.659430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.242000E-01 |
| Normal-vs-Extreme_Weight |
7.583600E-01 |
| Normal-vs-Obese |
5.640000E-01 |
| Normal-vs-Extreme_Obese |
7.865600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.623400E-01 |
| Normal_Weight-vs-Obese |
7.378600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.273800E-01 |
| Extreme_Weight-vs-Obese |
2.676600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.369600E-01 |
| Obese-vs-Extreme_Obese |
5.377400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.291440E-01 |
| Normal-vs-Age(41-60Yrs) |
2.791800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.948200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.346610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.189400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.064400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.103770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.390100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.363500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.117400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.190840E-01 |
| Normal-VS-Type2 PRCC |
2.130200E-02 |
| Normal-VS-KIRP CIMP |
4.875200E-01 |
| Normal-VS-Unclassified PRCC |
9.127600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.04520000011289E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.158640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.684400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.132400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.904500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.541000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.225000E-01 |
| Normal-vs-N1 |
7.312400E-01 |
| Normal-vs-N2 |
2.568100E-02 |
| N0-vs-N1 |
2.386600E-01 |
| N0-vs-N2 |
7.443500E-02 |
| N1-vs-N2 |
7.223900E-02 |
|
|
